Central Trust Company’s Medical Properties Trust MPT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$28.4K Buy
6,127
+1,300
+27% +$6.78K ﹤0.01% 951
2025
Q4
$24.1K Hold
4,827
﹤0.01% 940
2025
Q3
$24.5K Sell
4,827
-1,250
-21% -$5.51K ﹤0.01% 942
2025
Q2
$26.2K Hold
6,077
﹤0.01% 921
2025
Q1
$36.6K Buy
6,077
+577
+10% +$2.92K ﹤0.01% 853
2024
Q4
$21.7K Sell
5,500
-3,500
-39% -$15.7K ﹤0.01% 944
2024
Q3
$52.6K Sell
9,000
-1,660
-16% -$8.18K ﹤0.01% 775
2024
Q2
$45.9K Sell
10,660
-8,140
-43% -$39K ﹤0.01% 796
2024
Q1
$88.4K Sell
18,800
-2,450
-12% -$9.38K ﹤0.01% 700
2023
Q4
$104K Sell
21,250
-1,500
-7% -$7.34K ﹤0.01% 660
2023
Q3
$124K Sell
22,750
-3,060
-12% -$24.5K ﹤0.01% 627
2023
Q2
$239K Sell
25,810
-1,765
-6% -$14.9K 0.01% 529
2023
Q1
$227K Sell
27,575
-1,300
-5% -$14.4K 0.01% 523
2022
Q4
$322K Sell
28,875
-14,375
-33% -$167K 0.01% 453
2022
Q3
$513K Sell
43,250
-2,300
-5% -$34.8K 0.02% 369
2022
Q2
$696K Buy
45,550
+1,125
+3% +$20.2K 0.02% 333
2022
Q1
$939K Buy
44,425
+1,950
+5% +$42K 0.03% 323
2021
Q4
$1M Buy
42,475
+633
+2% +$13.6K 0.03% 327
2021
Q3
$840K Buy
41,842
+3,367
+9% +$69K 0.03% 345
2021
Q2
$773K Buy
38,475
+3,550
+10% +$75.9K 0.03% 348
2021
Q1
$743K Buy
34,925
+8,360
+31% +$180K 0.03% 342
2020
Q4
$579K Hold
26,565
0.02% 347
2020
Q3
$469K Buy
+26,565
New +$494K 0.02% 344
2020
Q2
Sell
-727
Closed -$13K 1116
2020
Q1
$13K Hold
727
﹤0.01% 826
2019
Q4
$15K Buy
+727
New +$14.7K ﹤0.01% 878
2018
Q4
Sell
-350
Closed -$5K 1210
2018
Q3
$5K Buy
+350
New +$5.1K ﹤0.01% 1126
2017
Q2
Sell
-250
Closed -$3K 1274
2017
Q1
$3K Hold
250
﹤0.01% 1082
2016
Q4
$3K Buy
250
+150
+150% +$1.94K ﹤0.01% 1110
2016
Q3
$1K Hold
100
﹤0.01% 1091
2016
Q2
$2K Buy
+100
New +$1.42K ﹤0.01% 1115
2015
Q3
Sell
-200
Closed -$3K 1227
2015
Q2
$3K Hold
200
﹤0.01% 1139
2015
Q1
$3K Buy
+200
New +$2.97K ﹤0.01% 1115

Other funds holding MPT

Central Trust Company's MPT Position: Q1 2026 in Review

Central Trust Company increased its Medical Properties Trust (MPT) stake by 27% in Q1 2026, buying an estimated $6.78K and bringing the position to 6,127 shares worth $28.4K. The position accounts for ﹤0.01% of the portfolio, ranked #951.

Central Trust Company first reported a position in MPT in Q1 2015 and has held it in 32 quarters since. The position peaked at $1M in Q4 2021. 491 funds tracked by Wall St. Rank hold MPT as of Q1 2026.

  • Central Trust Company held 6,127 shares of Medical Properties Trust worth $28.4K as of Q1 2026.
  • Central Trust Company bought 1,300 Medical Properties Trust shares in Q1 2026, an estimated $6.78K.
  • Medical Properties Trust made up ﹤0.01% of Central Trust Company's portfolio in Q1 2026, its #951 holding.
  • Central Trust Company first reported a position in Medical Properties Trust in Q1 2015 and has held it in 32 quarters since.
  • Central Trust Company's Medical Properties Trust position peaked at $1M in Q4 2021.
  • 491 funds tracked by Wall St. Rank held Medical Properties Trust as of Q1 2026.

Based on Central Trust Company's 13F filing for Q1 2026, filed 17 Apr 2026.